Radiopharma

Norway boasts decades of innovation, cutting-edge research, and top-tier companies in development, manufacturing, transport and distribution of radiopharmaceuticals.

It offers a complete radiopharma value chain, proton therapy and research centres, and world-class infrastructure for radiopharmaceutical trials. It is also a global hub for the emerging field of theranostics.

Norway excels in large-scale production and logistics of therapeutic radiopharmaceuticals and will soon offer local access to medical isotopes.

Moreover, Norway is located in the middle of the Nordic region and offers low electricity prices, making it an ideal location for energy-intensive production. Most production is powered by clean, renewable hydropower and Norwegian companies prioritise environmental and financial sustainability.